Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Recruits BIO Technical Affairs Staffer Goldhammer For Reg Affairs

Executive Summary

Alan Goldhammer, PhD, a sixteen-year veteran of representing the biotechnology industry in Washington, has moved to the regulatory affairs staff of the Pharmaceutical Research & Manufacturers of America.

You may also be interested in...



PhRMA Close To Deal With Tauzin; Changes In Reg Affairs, PR Line Up

The Pharmaceutical Research & Manufacturers of America is understood to be close to finalizing an agreement with Rep. Billy Tauzin (R-La.) to take over as the new CEO of the trade group

PhRMA Close To Deal With Tauzin; Changes In Reg Affairs, PR Line Up

The Pharmaceutical Research & Manufacturers of America is understood to be close to finalizing an agreement with Rep. Billy Tauzin (R-La.) to take over as the new CEO of the trade group

BIO Regulatory Affairs VP Woollett Brings CDER Experience From PhRMA

BIO VP-Science & Regulatory Affairs Gillian Woollett, PhD, will bring experience working with the Center for Drug Evaluation & Research to the biotech trade association

Related Content

UsernamePublicRestriction

Register

PS035057

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel